No abstract available
Plain language summary
This Medical News article discusses late-breaking science and other clinical highlights from the American Heart Association’s Scientific Sessions meeting.
MeSH terms
-
American Heart Association
-
Cardiovascular Diseases* / etiology
-
Cardiovascular Diseases* / prevention & control
-
Glucagon-Like Peptide-1 Receptor Agonists* / therapeutic use
-
Glucagon-Like Peptides / therapeutic use
-
Humans
-
Risk Assessment
-
United States
Substances
-
Glucagon-Like Peptides
-
semaglutide
-
Glucagon-Like Peptide-1 Receptor Agonists